Cargando...
Serum mesothelin and megakaryocyte potentiating factor in pancreatic and biliary cancers
BACKGROUND: Tumor mesothelin overexpression is present in different malignancies, including the majority of patients with pancreatic or biliary cancers. The objective of this study was to evaluate the use of shed serum mesothelin and megakaryocyte potentiating factor (MPF) concentrations as biomarke...
Guardado en:
| Publicado en: | Clin Chem Lab Med |
|---|---|
| Autores principales: | , , , , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2012
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6309905/ https://ncbi.nlm.nih.gov/pubmed/22149739 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1515/CCLM.2011.816 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|